Iron Out For Nontransfused Thalassemia

Individuals with β-thalassemia intermedia and hemoglobinopathies of equivalent severity who are infrequently or never transfused can still develop serious complications of iron overload. Taher et al report the first 1-year, randomized, double-blind, placebo-controlled trial of oral iron chelation therapy with deferasirox in this population.